English Português Dansk Deutsch Italiano Nederlands Русский Svenska 日本語 简体中文 繁體中文 한국어

Get In Touch

3 Park Avenue,
39th Fl
New York, NY 10016

33 Aldgate High Street
1st Fl
London, EC3N 1AH
33 Lockhart Rd,
19th Fl
Wan Chai, Hong Kong

Enter an address or city to search:

90 Cities

33 Countries

6 Continents

1 Global Partner

Privacy Policy
News Archive

TransPerfect Opens Remote Interpretation Facility in Arizona

TMCnet – September 21, 2011

TransPerfect, a provider of language services and translation-related technologies, announced the opening of a new remote interpretation facility in Arizona.

“We see this new facility as a key opportunity to fortify our existing resources in remote interpreting,” said Liz Elting, CEO of TransPerfect, in a statement. “The technology advances and bandwidth gains will deliver an immediate and significant improvement to the level of service we’re able to offer our clients.”

Leveraging the facility, TransPerfect will be able to improve the remote interpreting experience for its clients and their end users.

The new technology hosted on-site enables TransPerfect to supplement existing capabilities with increased call capacity, improved redundancy and security, and additional client service personnel.

TransPerfect is trying to tap a growing market. Remote language interpreting needs are growing. The company is offering device-independent connectivity in order to meet the diverse requirements of its clients.

TransPerfect is the world’s only provider of remote interpreting capabilities that support any device, including over-the-phone interpretation (OPI), Voice over IP (VoIP), Web-based audio, Web-based video, and all major video conferencing platforms. Its offers services in over 170 languages and features industry-specialist interpreters screened for subject expertise, according to company officials.

Recently, TransPerfect announced that Pearl Therapeutics implemented TransPerfect's Trial Interactive electronic Trial Master File (eTMF) solution for the company's clinical development programs.

Trial Interactive is a secure Web-based platform that eliminates the redundancies inherent in paper-based TMF studies. Trial Interactive complies with FDA's 21 CFR Part 11 regulation which outlines the requirements for maintenance of electronic records.